Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

BACKGROUND: To investigate the clinical utility of pretreatment plasma fibrinogen levels in malignant pleural mesothelioma (MPM) patients. METHODS: A retrospective multicenter study was performed in histologically proven MPM patients. All fibrinogen levels were measured at the time of diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanim, B, Hoda, M A, Klikovits, T, Winter, M-P, Alimohammadi, A, Grusch, M, Dome, B, Arns, M, Schenk, P, Jakopovic, M, Samarzija, M, Brcic, L, Filipits, M, Laszlo, V, Klepetko, W, Berger, W, Hegedus, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929892/
https://www.ncbi.nlm.nih.gov/pubmed/24434429
http://dx.doi.org/10.1038/bjc.2013.815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929892/
https://www.ncbi.nlm.nih.gov/pubmed/24434429
http://dx.doi.org/10.1038/bjc.2013.815

Ejemplares similares